Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
Doga M, Bonadonna S, Burattin A, Giustina A.
Ann Oncol. 2001;12 Suppl 2:S89-94. doi: 10.1093/annonc/12.suppl_2.s89.
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M, Doga M, Bonadonna S, Mazziotti G, Vescovi PP, Giustina A.
Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0.
Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.
Sano T, Asa SL, Kovacs K.
Endocr Rev. 1988 Aug;9(3):357-73. doi: 10.1210/edrv-9-3-357.
Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH.
Borges JL, Uskavitch DR, Kaiser DL, Cronin MJ, Evans WS, Thorner MO.
Endocrinology. 1983 Oct;113(4):1519-21. doi: 10.1210/endo-113-4-1519.
A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N, Teramoto A, Osamura RY, Genka S, Katakami H, Jin L, Lloyd RV, Kovacs K.
J Clin Endocrinol Metab. 1997 Aug;82(8):2731-7. doi: 10.1210/jcem.82.8.4175.
Uptake and ultrastructural localization of a [125I] growth hormone releasing factor agonist in male rat pituitary gland: evidence for internalization.
Morel G.
Endocrinology. 1991 Sep;129(3):1497-504. doi: 10.1210/endo-129-3-1497.
Covalent cross-linking of growth hormone-releasing factor to pituitary receptors.
Veliçelebi G, Patthi S, Provow S, Akong M.
Endocrinology. 1986 Apr;118(4):1278-83. doi: 10.1210/endo-118-4-1278.
A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.
Asa SL, Scheithauer BW, Bilbao JM, Horvath E, Ryan N, Kovacs K, Randall RV, Laws ER Jr, Singer W, Linfoot JA, et al.
J Clin Endocrinol Metab. 1984 May;58(5):796-803. doi: 10.1210/jcem-58-5-796.
Pancreatic endocrine tumour producing growth hormone-releasing hormone associated with multiple endocrine neoplasia type I syndrome.
Asa SL, Singer W, Kovacs K, Horvath E, Murray D, Colapinto N, Thorner MO.
Acta Endocrinol (Copenh). 1987 Jul;115(3):331-7. doi: 10.1530/acta.0.1150331.
Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome.
Ramsay JA, Kovacs K, Asa SL, Pike MJ, Thorner MO.
Cancer. 1988 Jul 15;62(2):445-50. doi: 10.1002/1097-0142(19880715)62:2<445::aid-cncr2820620233>3.0.co;2-5.
